In the past two decades, advances in sequencing technology and analysis of the human and
mouse genome have led to the discovery of many non-protein-coding RNAs (ncRNAs) …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder. AD is characterized
by the production and aggregation of beta-amyloid (Aβ) peptides, hyperphosphorylated tau …

Neurodegenerative diseases such as Alzheimer's disease (AD) are characterized by the
progressive loss of neurons in the brain and the spinal cord. The pathophysiology of AD is …

Alzheimer's disease (AD) is a complex neurodegenerative disorder and the most common
dementia among the elderly. Accumulating research indicates that noncoding RNAs …

Alzheimer's disease is a devastating neurodegenerative disorder affecting a significant
portion of the world's rapidly growing aging population. In spite of its prevalence, the etiology …

Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder and represents
the most common form of senile dementia. The pathogenesis of AD is not yet completely …

The emerging complexity of the transcriptional landscape poses great challenges to our
conventional preconceptions of how the genome regulates brain function and dysfunction …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder that is accompanied by
deficits in memory and cognitive functions. The disease is pathologically characterised by …

Alzheimer's disease (AD) is one of the most common causes of dementia. Although
significant breakthroughs have been made in understanding the progression and …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most
common dementia among the elderly. The pathophysiology of AD is characterized by two …